HeartSciences Inc. Nov 22, 2026 Copy link HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining Transaction remains subject to Nasdaq approval and other closing conditions Business
HeartSciences Inc. Oct 21, 2026 Copy link HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining Shareholder Special Meeting Scheduled for November 19, 2026 Business
HeartSciences Inc. Oct 6, 2026 Copy link HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the Business
HeartSciences Inc. Sep 15, 2026 Copy link HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, Business
HeartSciences Inc. Aug 19, 2026 Copy link Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration Shares issued at $2.43, a 22% premium to the closing price on the purchase date, with Fortitude receiving no additional Business
HeartSciences Inc. Jul 29, 2026 Copy link HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation Business
HeartSciences Inc. Jul 23, 2026 Copy link HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K Company believes proposed Fortitude merger represents a significant opportunity for the Company’s shareholders; Business
HeartSciences Inc. Jun 11, 2026 Copy link European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents Patent covers machine-learning models that use ECG data to estimate echocardiogram parameters indicative of diastolic Business
HeartSciences Inc. Jun 2, 2026 Copy link HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first Business